David Allen Sutton

US Patent:

6613158, Sep 2, 2003

Filed:

Jun 4, 2002

Appl. No.:

10/162352

Inventors:

Stephen F. Gross - Souderton PA
David C. Sutton - Racine WI

Assignee:

Cognis Corporation - Gulph Mills PA
Johnson Diversey, Inc. - Sturtevant WI

International Classification:

C11D 104

US Classification:

134 40, 134 252, 134 253, 134 39, 134 42, 510101, 510200, 510238, 510239, 510240, 510241, 510243, 510244, 510245, 510434, 510476, 510488, 510503

Abstract:

A chewing gum remover composition containing: (a) a C alkyl ester of a C saturated or unsaturated carboxylic acid; (b) a terpene; and (c) optionally, an oil-soluble surfactant, and wherein (a) and (b) are present in the composition in a ratio by weight of from about 10:1 to about 1:10.

US Patent:

D634708, Mar 22, 2011

Filed:

Sep 10, 2010

Appl. No.:

29/369659

Inventors:

David M. Cowan - Brooklyn NY, US
Ronald S. Shapiro - Toledo OH, US
David B. Sutton - Monroe MI, US
Pepin S. Gelardi - Brooklyn NY, US

Assignee:

Physician's Technology, LLC - Monroe MI

International Classification:

1302

US Classification:

D13108

US Patent:

D649257, Nov 22, 2011

Filed:

Sep 10, 2010

Appl. No.:

29/369664

Inventors:

David M. Cowan - Brooklyn NY, US
Ronald S. Shapiro - Toledo OH, US
David B. Sutton - Monroe MI, US
Pepin S. Gelardi - Brooklyn NY, US

Assignee:

Physician's Technology, LLC - Monroe MI

International Classification:

2803

US Classification:

D24209

US Patent:

D650486, Dec 13, 2011

Filed:

Sep 10, 2010

Appl. No.:

29/369638

Inventors:

David M. Cowan - Brooklyn NY, US
Ronald S. Shapiro - Toledo OH, US
David B. Sutton - Monroe MI, US
Pepin S. Gelardi - Brooklyn NY, US

Assignee:

Physician's Technology, LLC - Monroe MI

International Classification:

2803

US Classification:

D24209

US Patent:

20070207996, Sep 6, 2007

Filed:

Aug 30, 2005

Appl. No.:

11/660460

Inventors:

Kurt Auger - Collegeville PA, US
Jeffrey Jackson - Collegeville PA, US
David Sutton - Collegeville PA, US

International Classification:

A61K 31/517
A61K 31/7072
A61K 31/704
A61K 31/282
A61K 31/4745
A61K 33/24

US Classification:

514210210, 514266200, 514266300, 514266220, 514034000, 514049000, 514492000, 514283000, 514449000, 424649000

Abstract:

Disclosed inter alia is the use of quinazolinone derivatives, which are modulators of a mitotic kinesin such as KSP, in the treatment of cellular proliferative diseases. The quinazolinone derivatives are administered with another chemotherapeutic agent selected from alkylating agents, antimetabolites, platinating agents, topoisomerase inhibitors, tubulin agents and signalling inhibitors (e.g., kinase inhibitors). Pharmaceutical compositions comprising one or both types of active agents are also disclosed.

US Patent:

59168935, Jun 29, 1999

Filed:

Apr 25, 1997

Appl. No.:

8/845720

Inventors:

Hugh John Field - Cambridge, GB
Alana Maureen Thackray - Cambridge, GB
Teresa Helen Bacon - Epsom, GB
David Sutton - Phoenixville PA
Richard Anthony Vere Hodge - Reigate, GB

Assignee:

SmithKline Beecham p.l.c. - Brentford

International Classification:

A61K 3152

US Classification:

514262

Abstract:

A method for the treatment of latent infection of herpesviruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing.

US Patent:

58407634, Nov 24, 1998

Filed:

Sep 1, 1995

Appl. No.:

8/522790

Inventors:

Hugh John Field - Cambridge, GB2
Alana Maureen Thackray - Cambridge, GB2
Teresa Helen Bacon - Weybridge, GB2
David Sutton - Wayne PA
Richard Anthony Vere Hodge - Reigate, GB2

Assignee:

SmithKline Beecham plc - Brentford

International Classification:

A61K 3152

US Classification:

514262

Abstract:

A method for the treatment of latent infection of herpesviruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing.

US Patent:

20180042356, Feb 15, 2018

Filed:

Aug 12, 2016

Appl. No.:

15/235389

Inventors:

- CITY CENTRE, IE
David Michael Sutton - Brooklyn NY, US

Assignee:

Mohawk Innovations Limited - CITY CENTRE

International Classification:

A45D 20/12
A45D 40/00

Abstract:

This invention relates to a refillable and/or interchangeable cartridge that can attach and detach from a hairdryer. Prior to, concurrent with or subsequent to hair drying, a user can activate the cartridge to dispel, mist, steam or otherwise disperse the cartridge's product onto the user's hair, skin, scalp or fur. Each cartridge can contain various hair treatment products, styling products and/or nutrients. A cartridge can attach and detach at various points along the hairdryer including but not limited to inside the front outlet or rear inlet, primarily annularly around either the front outlet or rear inlet, along the top of the housing, through the core of the housing, or in the handle. The hairdryer also has improved heat transfer, fluid flow, reduced noise and vibration, weight and a shorter main housing barrel to make it easier for a user to treat and style the user's hair, skin, scalp or fur.